🇺🇸 FDA
Company

Coherus

Coherus Oncology

CHRS biotech USA

Quick answer

Coherus is a biotech company (CHRS) headquartered in REDWOOD CITY, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

CHS-0214

Rheumatoid Arthritis

Phase 3 · small_molecule · completed

1 trials project

CHS-1420

Plaque Psoriasis

Phase 3 · small_molecule · completed

1 trials project

Etanercept

Rheumatoid Arthritis

Phase 3 · small_molecule · completed

1 trials project

Etanercept

Plaque Psoriasis

Phase 3 · small_molecule · completed

1 trials project

Casdozokitug

Hepatocellular Carcinoma

Phase 2 · small_molecule · active

1 trials project

Dupilumab

Metastatic Colorectal Cancer

Phase 2 · small_molecule · active

1 trials project

NY-ESO-1 Peptide vaccine

Ovarian Cancer Stage IV

Phase 2 · mab · active

1 trials project

Nadunolimab

Metastatic Microsatellite Stable Colorectal Carcinoma

Phase 2 · small_molecule · active

1 trials project

SRF388

Hepatocellular Carcinoma

Phase 2 · small_molecule · completed

1 trials project

STC-15 in combination with toripalimab

Solid Tumor

Phase 2 · other · active

1 trials project

Toripalimab

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)

Phase 2 · small_molecule · active

1 trials project

Toripalimab

Localized Colon Carcinoma

Phase 2 · small_molecule · active

1 trials project

Toripalimab

Sinonasal Cancer

Phase 2 · small_molecule · active

1 trials project

Toripalimab + Chemotherapy

Head and Neck Cancer

Phase 2 · small_molecule · active

1 trials project

Toripalimab-tpzi

Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

CHS-006 (anti-TIGIT)

Advanced Solid Tumor

Phase 1 · small_molecule · terminated

1 trials project

CHS-1000

Advanced or Metastatic Solid Tumors

Phase 1 · mab · active

1 trials project

CHS-114

Metastatic Solid Tumor

Phase 1 · small_molecule · active

1 trials project

CHS-114

Advanced Solid Tumor

Phase 1 · small_molecule · active

1 trials project

CHS-1701

Immunity, Humoral

Phase 1 · small_molecule · completed

1 trials project

CHS-1701

Healthy

Phase 1 · small_molecule · completed

1 trials project

CHS-1701

Bioequivalence

Phase 1 · small_molecule · completed

1 trials project

CHS-388

Advanced Solid Tumor

Phase 1 · small_molecule · completed

1 trials project

SRF617

Advanced Solid Tumor

Phase 1 · small_molecule · completed

1 trials

Drugs (3)

drug

adalimumab-aqvh

YUSIMRY

 drug

pegfilgrastim-cbqv

UDENYCA

 drug

toripalimab-tpzi

LOQTORZI

Patents (8)

patent

US 11667702

Stable aqueous formulations of aflibercept

Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11583584

Stable protein compositions and methods of their use

Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11576971

Method of filling a container with no headspace

Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11426446

Stable aqueous formulations of aflibercept

Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11400072

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrop

Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11396540

Methods for making recombinant proteins

Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11253508

PPARy agonist for treatment of progressive supranuclear palsy

Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11229702

High concentration formulations of adalimumab

Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)